The Ischemic Extremity: New Findings and Treatment |
Wat mensen zeggen - Een review schrijven
We hebben geen reviews gevonden op de gebruikelijke plaatsen.
Inhoudsopgave
Critical Limb Ischemia | 3 |
EPIDEMIOLOGY AND NATURAL HISTORY | 4 |
PATHOPHYSIOLOGY | 5 |
MODIFIABLE RISK FACTORS | 8 |
TREATMENT | 9 |
PATIENTORIENTED OUTCOMES | 12 |
FUTURE DIRECTION | 14 |
CONCLUSION | 15 |
REFERENCES | 249 |
The Use of Negative Pressure Wound Therapy in Clinical Practice | 251 |
CELLULAR STUDIES AND MICRO DEFORMATIONAL WOUND THERAPY | 253 |
CONCLUSION | 261 |
Practical Strategies for Debridement Offloading and Healing the Diabetic Foot Wound | 265 |
TREATMENT | 266 |
CONCLUSION | 272 |
Advances in Amputation and Prosthesis | 275 |
REFERENCES | 16 |
Exercise Training Programs for Patients with Intermittent Claudication | 21 |
BENEFITS OF SUPERVISED TREADMILL EXERCISE PROGRAMS IN PATIENTS WITH PAD | 22 |
EXERCISE REHABILITATION AND FUNCTIONAL OUTCOMES IN PERSONS WITH PERIPHERAL ARTERIAL DISEASE AND INTERMITTE... | 24 |
SAFETY OF EXERCISE REHABILITATION | 25 |
MAINTENANCE OF GAINS ACHIEVED DURING EXERCISE REHABILITATION IN PAD | 26 |
SELFDIRECTED WALKING EXERCISE AND RATES OF FUNCTIONAL DECLINE IN PERIPHERAL ARTERIAL DISEASE | 27 |
MECHANISMS BY WHICH WALKING EXERCISE INCREASES PAINFREE AND MAXIMAL WALKING DISTANCE IN INTERMITTENT CLA... | 28 |
UPPER AND LOWER LIMB AEROBIC EXERCISE IN PERIPHERAL ARTERIAL DISEASE | 29 |
LOWER EXTREMITY STRENGTH TRAINING IN PERIPHERAL ARTERIAL DISEASE | 30 |
POTENTIAL BARRIERS TO PARTICIPATION IN EXERCISE TRAINING PROGRAMS | 31 |
CONCLUSION | 32 |
Value of Preoperative Duplex Scanning in Planning Infrainguinal Bypass | 35 |
REFERENCES | 40 |
Infrainguinal Graft Duplex Surveillance Detection and Treatment of Graft Threatening Lesions | 43 |
POSTOPERATIVE VEIN GRAFT EVALUATION | 44 |
RATIONALE FOR SURVEILLANCE | 45 |
GRAFT REVISION | 50 |
INTERVENTION FOR GRAFT STENOSIS | 52 |
ARTERIAL DISEASE PROGRESSION | 54 |
REFERENCES | 55 |
Statin Management for Vascular Surgery Patients | 59 |
WHAT ARE STATINS? | 60 |
DIRECT BENEFICIAL EFFECTS OF STATINS FOR VASCULAR PATIENTS | 61 |
STATIN USE IN A VASCULAR PRACTICE | 64 |
COMPLICATIONS WITH STATIN USE | 65 |
REFERENCES | 66 |
Antiplatelet Medication in Patients with Vascular Disease and Following Interventions | 69 |
ROLE OF PLATELETS IN ATHEROSCLEROSIS ARTERIAL THROMBOSIS BYPASS GRAFT OCCLUSION AND RESTENOSIS AFTER PERCU... | 70 |
ANTIPLATELET AGENTS | 71 |
PROTECTION FROM MAJOR CARDIOVASCULAR MORBIDITY MYOCARDIAL INFARCTION STROKE OR DEATH | 72 |
ANTIPLATELET EFFECT ON BYPASS GRAFT PATENCY | 74 |
ANTIPLATELET EFFECT FOLLOWING PERIPHERAL PERCUTANEOUS INTERVENTION | 75 |
REFERENCES | 77 |
The Use of Antithrombins as Alternatives to Conventional Anticoagulation | 79 |
THROMBOGENESIS | 80 |
SUMMARY | 84 |
Is RevascularizationLimb Salvage Always the Best Treatment for Patients with Critical Limb Ischemia? | 87 |
PROGNOSIS OF CLI | 88 |
FUNCTIONAL STATUS OF PATIENTS WITH CLI | 89 |
ALTERNATIVES TO REVASCULARIZATION FOR CLI | 91 |
POSSIBLE APPROACHES TO CURRENT TREATMENT OF CLI | 92 |
REFERENCES | 93 |
Burning Bridges Is the Application of Emerging Technologies Deleterious to the Care of the Vascular Patient and the Nations Financial Resources? | 95 |
THE SURGICAL SAFETY NET ARGUMENT | 96 |
EAST CAROLINA EXPERIENCE WITH SECONDARY BYPASS | 97 |
CONCLUSIONS | 100 |
Percutaneous Intervention for Limb Ischemia | 103 |
Endovascular Therapy is the Preferred Initial Treatment for all Lower Extremity Revascularization | 105 |
NATURAL HISTORY | 106 |
PATIENT LONGEVITY WITH LOWER EXTREMITY REVASCULARIZATION | 107 |
PERIPROCEDURAL COMPLICATIONS | 108 |
FUNCTIONAL OUTCOME | 109 |
PATENCY AND REINTERVENTION | 110 |
WHAT IS THE CONSEQUENCE OF FAILURE? | 111 |
REFERENCES | 112 |
Techniques to Treat Chronic Total Iliac Artery Occlusions | 115 |
LESION CHARACTERISTICS AND PATIENT SELECTION | 116 |
DETERMINING THE SITE OF ACCESS | 117 |
CROSSING TOTAL OCCLUSIONS | 118 |
RECONSTRUCTION OF ILIAC CTOs | 123 |
COMPLICATIONS OF ILIAC ARTERY ANGIOPLASTY AND STENTING | 124 |
CONCLUSIONS | 125 |
Angioplastybased Infrainguinal Percutaneous Interventions | 127 |
CLINICAL SERIES | 128 |
INFRAPOPLITEAL PTA RESULTS | 130 |
NITINOL SELFEXPANDING STENTS | 131 |
NOVEL TECHNOLOGIES AND TECHNIQUES FOR INFRAINGUINAL PERCUTANEOUS INTERVENTIONS | 132 |
BIODEGRADABLE STENTS | 135 |
CONCLUSIONS | 136 |
REFERENCES | 137 |
Remote Superficial Femoral Artery Endarterectomy | 139 |
RSFAE PHASE | 140 |
RESULTS | 141 |
RSFAE AND DISTAL ASPIRE STENTING | 142 |
DISCUSSION | 143 |
RSFAE AND DISTAL VEIN BYPASS | 145 |
CONCLUSION | 146 |
Subintimal Angioplasty for the Treatment of Lower Extremity Ischemia | 149 |
TECHNIQUE | 150 |
CASE DESCRIPTIONS | 151 |
DISCUSSION | 155 |
SUMMARY | 158 |
The Role of Atherectomy in Lower Extremity Arterial Occlusive Disease | 161 |
STUDIES | 164 |
COMPLICATIONS | 166 |
APPLICATIONS | 167 |
Open Surgical Revascularization in the Endovascular Era | 169 |
Improving Lower Extremity Bypass Patency | 171 |
PATIENT SELECTION | 173 |
CURRENT LOWER EXTREMITY BYPASS TECHNIQUES | 175 |
MEDICAL ADJUNCTS | 177 |
A COMPREHENSIVE PROGRAM | 178 |
REFERENCES | 179 |
A 20year Experience with Infrapopliteal Prosthetic Graft | 183 |
DATA ANALYSIS | 184 |
RESULTS | 186 |
INFRAPOPLITEAL ANGIOPLASTY FOR CRITICAL LIMB ISCHEMIA | 190 |
SUMMARY | 192 |
Lower Limb Revascularization in Patients with Diabetes Mellitus | 195 |
ARTERIAL IMAGING | 199 |
STRATEGIES FOR DISTAL BYPASS | 200 |
PROFUNDA FEMORIS ARTERY | 203 |
PROCEDURES ON THE PROFUNDA | 204 |
REFERENCES | 205 |
Vein Bypass Grafts to the Dorsalis Pedis Artery | 207 |
REFERENCES | 213 |
Unusual Exposure for Lower Extremity Revascularization | 215 |
LATERAL APPROACHES | 217 |
POSTERIOR APPROACH | 220 |
COMMENTS | 223 |
REFERENCES | 224 |
Surgical Management of Femoral and Popliteal Artery Aneurysms | 225 |
POPLITEAL ARTERY ANEURYSM | 226 |
FEMORAL ANEURYSM | 232 |
FEMORAL ARTERY PSEUDOANEURYSM | 234 |
REFERENCES | 238 |
Advances in Wound Care and Amputation | 241 |
The Healing of Infection Ulceration and Minor Amputation Revascularization in Patients with Diabetes | 243 |
SURGICAL APPROACH TO THE PATIENT WITH DIABETES MELLITUS | 245 |
TISSUE LOSS AND ULCERATION | 246 |
MINOR AMPUTATION | 247 |
CONCLUSIONS | 248 |
REFERENCES | 284 |
Management of Complications after Revascularization | 287 |
Management of Arterial Closure Device Complications | 289 |
ARTERIAL OCCLUSION AND DISSECTION | 290 |
PSEUDOANEURYSMS | 292 |
DEVICE MALFUNCTIONENTRAPMENT | 293 |
Treatment of Infected Bare Metal Stents The Naked Truth about Problems Bugging Our Patients | 295 |
RISK FACTORS | 296 |
ETIOLOGY | 299 |
DIAGNOSIS | 300 |
TREATMENT | 302 |
PREVENTION | 305 |
CONCLUSION | 310 |
Treatment of Atheroembolism with IntraArterial Injection of Prostaglandin E1 | 313 |
HISTORICAL PERSPECTIVE | 314 |
EPIDEMIOLOGY AND INCIDENCE | 315 |
SOURCES OF MICROEMBOLI | 316 |
CLINICAL FEATURES | 319 |
DIAGNOSTIC STRATEGIES | 322 |
DIFFERENTIAL DIAGNOSIS | 323 |
MANAGEMENT STRATEGIES FOR ATHEROEMBOLISM | 324 |
SURGICAL THERAPY | 334 |
ENDOVASCULAR TREATMENT | 335 |
PAIN CONTROL | 336 |
REFERENCES | 337 |
Inguinal Wound Complications Lymphatic Leak Lymphoceles and Graft Infections | 343 |
LYMPH LEAKS | 345 |
LYMPHOCELES | 346 |
PROPHYLATIC MEASURES | 347 |
REFERENCES | 349 |
Soft Tissue Reconstruction of the Groin after Vascular Surgery Use of the Gracilis Muscle Flap | 351 |
ABDOMINAL FLAPS | 353 |
SURGICAL ANATOMY AND TECHNIQUE | 354 |
RESULTS | 359 |
REFERENCES | 360 |
Emerging Biotechnology Techniques for Treatment of Limb Ischemia | 361 |
The Use of Stem Cells in the Treatment of Inoperable Limb Ischemia | 363 |
GENE THERAPY AND GROWTH FACTORS FOR CHRONIC LIMB ISCHEMIA | 364 |
EXCLUSION CRITERIA | 366 |
COMMENTS | 368 |
REFERENCES | 369 |
Nitric Oxidebased Therapies in Vascular Disease | 371 |
DEVELOPMENT OF NEOINTIMAL HYPERPLASIA FOLLOWING ARTERIAL INJURY | 372 |
NO PREVENTS NEOINTIMAL HYPERPLASIA | 375 |
OUR APPROACH | 378 |
CONCLUSION | 381 |
Bioengineered Arteries | 385 |
CELLASSISTED ASSEMBLY OF MATRIX PROTEINS | 386 |
DECELLULARIZED ALLO AND XENOGENEIC TISSUE ARTERIAL SUBSTITUTES | 387 |
FUTURE DIRECTIONS IN ARTERIAL BIOENGINEERING | 388 |
REFERENCES | 389 |
Modified Prosthetic Vascular Conduits | 393 |
SURGICAL MODIFICATIONS OF PROSTHETIC VASCULAR GRAFTS | 396 |
CHEMICAL AND BIOLOGICAL MODIFICATIONS OF PROSTHETIC VASCULAR GRAFTS | 398 |
CONCLUSION | 406 |
REFERENCES | 407 |
Arterial Trauma | 411 |
The Intraoperative Consult | 413 |
POSTOPERATIVE CLINICAL RESPONSIBILITIES | 416 |
MEDICALLEGAL CONSIDERATIONS | 417 |
CONCLUSION | 418 |
Iatrogenic IntraAbdominal and Pelvic Vascular Injuries | 419 |
IATROGENIC INTRAABDOMINAL AND PELVIC ARTERY TRAUMA | 420 |
IATROGENIC VENOUS INJURIES OF THE ABDOMEN AND PELVIS | 422 |
CONCLUSION | 424 |
Acute Arterial Complications of Total Hip and Knee Arthroplasty | 427 |
OPERATIVE ASPECTS | 429 |
DIAGNOSIS | 430 |
TREATMENT | 431 |
REFERENCES | 433 |
Lower Extremity Vascular Injury in Children Younger than 13 Years of Age | 435 |
PRESENTATION | 436 |
CONFIRMATORY DIAGNOSTIC STUDIES | 438 |
MANAGEMENT | 439 |
RESULTS | 443 |
CONCLUSIONS | 445 |
REFERENCES | 447 |
Popliteal Trauma | 451 |
CLINICAL EVALUATION | 452 |
SURGICAL MANAGEMENT OF POPLITEAL INJURIES | 457 |
UNIVERSITY OF MARYLAND EXPERIENCE | 459 |
ASSOCIATED TOPICS | 460 |
SUMMARY | 461 |
The Management of Upper Extremity Arterial Trauma | 463 |
ENDOVASCULAR MANAGEMENT OF UPPER EXTREMITY VASCULAR INJURIES | 464 |
OPERATIVE MANAGEMENT OF UPPER EXTREMITY VASCULAR TRAUMA | 465 |
MEDIAN STERNOTOMY | 466 |
ANTERIOR THORACOTOMY | 467 |
SUPRACLAVICULAR APPROACH | 469 |
INFRACLAVICULAR INCISION | 471 |
FOREARM FASCIOTOMY | 472 |
CONCLUSION | 473 |
REFERENCES | 474 |
Upper Extremity Ischemia | 477 |
Quality Measures in Thoracic Outlet Syndrome | 479 |
PRESENTATION | 480 |
DIAGNOSIS | 481 |
TREATMENT | 485 |
RECURRENT TOS | 486 |
PROGNOSIS | 487 |
Arterial Injuries in Thoracic Outlet Compression | 489 |
PATHOPHYSIOLOGY AND ANATOMY | 490 |
PRESENTATION | 492 |
TREATMENT | 493 |
COMMENT | 495 |
Supraclavicular Paraclavicular Approach for Thoracic Outlet Syndrome | 497 |
SUPRACLAVICULAR EXPOSURE ALL FORMS OF TOS | 498 |
INFRACLAVICULAR EXPOSURE FOR NEUROGENIC TOS | 503 |
INFRACLAVICULAR EXPOSURE FOR VENOUS TOS | 504 |
SUBCLAVIAN VEIN RECONSTRUCTION FOR VENOUS TOS | 506 |
CLOSURE AND POSTOPERATIVE CARE | 509 |
| 510 | |
Axillary Approach for Thoracic Outlet Syndrome | 511 |
| 516 | |
Palmar Ulnar Artery Aneurysms | 517 |
REFERENCES | 522 |
Hand Ischemia in EndStage Renal Disease | 525 |
ISCHEMIC STEAL IN PATIENTS WITH ARTERIOVENOUS FISTULAE | 526 |
HAND ISCHEMIA IN PATIENTS WITH ESRD | 527 |
DISCUSSION | 529 |
REFERENCES | 530 |
| 533 | |
Veelvoorkomende woorden en zinsdelen
activity amputation aneurysms angioplasty approach arterial disease artery associated blood bypass grafts catheter cause cells claudication clinical common compared complications conduit critical demonstrated device diabetic disease distal duplex early effect embolization endovascular et al evaluation exercise experience factors failure femoral Figure flow foot functional healing iliac improved incision increased infection infrainguinal initial injury intervention involvement ischemia ischemic lateral lesions less limb ischemia limb salvage lower extremity major months mortality muscle myocardial infarction nerve occlusion occur operation outcomes pain patency patients performed peripheral popliteal popliteal artery postoperative present primary procedures prosthetic proximal randomized rates reconstruction removed renal repair reported revascularization risk significant statins stenosis stent subclavian success surgeon surgery surgical technique therapy tibial tion tissue trauma treated treatment trial ulcers undergoing Vasc Surg vascular Vascular Surgery vein graft vessels walking wound

